Skip to Content
COVID-19 Resources
Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 10/28/16

NCI Holds Workshop on Regulatory Pathways for Clinical Use of Optical Imaging

NCI-ISIGS-WMIS Workshop on Regulatory Pathways for Clinical Use of Optical Methods and Exogenous Targets for Cancer Detection

Posted on July 05, 2016

Optical imaging is rapidly becoming a useful tool in detecting surface malignancies as well as improving the tumor margins during surgical resections, thereby potentially catching lesions in a less advanced state and also decreasing tumor recurrence. However, there is a gap in the pace of clinical evaluation of these novel agents and devices, partly due to a lack of understanding of the regulatory pathways that need to be followed. The mission of the Cancer Imaging Program includes facilitating clinical evaluation of promising methodologies that can improve cancer care. To this end, we are hosting a one day workshop along with the FDA and two professional societies — the International Society of Image Guided Surgery (ISIGS) and the World Molecular Imaging Society (WMIS) to discuss these issues on May 4th, 2016.

Workshop Participant List
Workshop Agenda
Powerpoint Slides from the Workshop (no video)*
Link to Full Videocast of Workshop:*

*Contains graphic images of post-surgical tissue samples which may be disturbing for certain viewers